National policy on research & development and innovation in the pharma-med tech sector in India
The Department of Pharmaceuticals (DoP) has notified the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector in India with reforms in terms of regulatory framework and streamlining processes reducing the approval timelines, incentivising investment in innovation and creation of an enabling ecosystem for innovation and research.
